Table Of Content

Subject index of volume 108 Abstinence 495 Chick 235 Facilitation 443 Acetylcholine 417 Chlordiazepoxide 72, 263 Fear 352 Acetylcholinesterase-inhibitor 103 Chlorpromazine 289, 338, 345 FG 7142 185, 205 Acoustic startle response 40, 189 Cholinomimetics 11 Flumazenil 147 ACTH 27 Chronic cocaine treatment 263 Fluphenazine 338 Addiction 218, 397, 408 Chronic exposure 51 Food consumption 501 Adrenalectomy 27 Chronic treatment 33 FR 115 a-Adrenergic antagonists, atipamezole Cigarette 452 229 Cigarette smoking 1, 460, 495, 512 GABA 196 a-Adrenergic receptor 313 Clonazepam 131 Genetic 136 a,-Adrenergic antagonists, prazosin Clonidine 159, 283 Gepirone 289 229 Clovoxamine 327 Guanfacine 159 a&2-Adrenergic agonists, dexmedetomi- Cocaine 256, 295 dine 229 Cocaine abuse 289 Haloperidol 141, 338 Aerosol 519 Cocaine discontinuation 263 5-HT. receptor 387 Aggression 177, 196, 276 Cold pressor pain 60 5-HT3 333 Agonistic behavior 196 Conditioning 218 5-HT,, 123, 320 Alcohol 276 Conflict schedule 185 5-HT,, agonists 47 Alternative reinforcer 295 Consolidation 448 5-HT,, receptor 110 Alzheimer's disease 103, 480, 485 Continuous performance task reaction 5-HT,, receptors 85, 380 Ambulatory activity 271 time 437 5-HT,, 123 Amitriptyline 327 Controlled dosing 519 Human 103, 225, 345, 371 Amygdala 189 Corticosteroids 11 Human brain 16 Analgesia 60 Corticosterone 27, 33 Humans 51, 60 Animal behavior 196 Cortisol 153, 313 Animal model 352 Cortisol response 519 Idazoxan 313 Animal model of alcoholism 136 Cotinine 507 Imipramine 23 Animal models of anxiety 205 Cue learning 147 In vitro autoradiography 16 Antagonist 320 "C 16 Individuality 67 Anticholinergic 327 Infantile stimulation 170 Antidepressants 23, 93 Information processing 485 Defensive behavior 205 Antidepressants 327 Inhibitory avoidance learning 131 Demand 1 Antiepileptic drugs 131 Insomnia 67 Dementia 103 Antipredator defense 352 Inverse agonist 185 Dependence 218, 333, 408, 507 Antipsychotics 98 Depression 93 Anxiety 213, 313, 333, 352, 387 Kappa opioid receptor 235 Desipramine 363 Anxiogenic property 205 Ketanserin 27 Development 256 Anxiolysis 229 Ketanserine 210 Diazepam 131, 147, 301, 371 Apomorphine 47, 72, 367 Discrete-trials choice 295 Arginine-vasopressin 225 Late luteal phase dysphoric disorder DO! 27 Arousal 456 153 Dopa decarboxylase 98 Attention 159, 485 Lateralisation 473 Dopamine 72, 177, 189, 256, 345, 367 Aversion 110 Learning 345, 480 Dopamine antagonists 289 Lithium 93 Dose-related 460 Locomotion 177, 196 Behavioral economics 1 Doxazosine 283 Locomotor activity 352, 367 Behaviour 283 DRL 115 Locus coeruleus 23 Benzodiazepine 72, 333 Drug abuse 60 Long-term memory 448 Benzodiazepine agonist, midazolam Drug discrimination 85 Lorazepam 345, 371 229 Drug interactions 115 Benzodiazepine antagonist, flumazenil Drug selfadministration 1 m-chlorophenylpiperazine 225 229 Drug stimulus exposure 495 MCPP 320 Benzodiazepine physical dependence Dynorphin 235 Mecamylamine 417, 480 301 D2 receptors 47 Memory 159, 235, 327, 345, 371, 417, Benzodiazepine receptors 16 443, 452 Benzodiazepines 147, 196, 248, 371 EEG 473 Memory improvement 11 Beta-CCE 205 Electroconvulsive treatment 367 Mesolimbic dopamine system 141 Blood pressure 313 Elevated plus-maze 229 Methamphetamine sensitivity 271 Body weight 501 Emotional reactivity 170 MHPG 313 Brain levels 338 B-endorphin 153 Mice 131, 271, 276, 367 Bromperidol 338 Ethanol 301 Microeconomics 1 Bungarotoxin-receptors 33 Ethanol intake 136 MK-801 115, 271, 352, 367 Buspirone 289, 380 Etoperidone 320 Monkey brain 16 Euphoriant effects 460 Mood 60 Caffeine 51 Examination anxiety 456 Morphine 40, 60, 147, 283 Carbamazepine 131 Excitatory amino acid 110 Morphine-6-glucuronide 60 Carbon monoxide 466 Exploration 170 Morris water maze 147 Subject index of volume 108 Abstinence 495 Chick 235 Facilitation 443 Acetylcholine 417 Chlordiazepoxide 72, 263 Fear 352 Acetylcholinesterase-inhibitor 103 Chlorpromazine 289, 338, 345 FG 7142 185, 205 Acoustic startle response 40, 189 Cholinomimetics 11 Flumazenil 147 ACTH 27 Chronic cocaine treatment 263 Fluphenazine 338 Addiction 218, 397, 408 Chronic exposure 51 Food consumption 501 Adrenalectomy 27 Chronic treatment 33 FR 115 a-Adrenergic antagonists, atipamezole Cigarette 452 229 Cigarette smoking 1, 460, 495, 512 GABA 196 a-Adrenergic receptor 313 Clonazepam 131 Genetic 136 a,-Adrenergic antagonists, prazosin Clonidine 159, 283 Gepirone 289 229 Clovoxamine 327 Guanfacine 159 a&2-Adrenergic agonists, dexmedetomi- Cocaine 256, 295 dine 229 Cocaine abuse 289 Haloperidol 141, 338 Aerosol 519 Cocaine discontinuation 263 5-HT. receptor 387 Aggression 177, 196, 276 Cold pressor pain 60 5-HT3 333 Agonistic behavior 196 Conditioning 218 5-HT,, 123, 320 Alcohol 276 Conflict schedule 185 5-HT,, agonists 47 Alternative reinforcer 295 Consolidation 448 5-HT,, receptor 110 Alzheimer's disease 103, 480, 485 Continuous performance task reaction 5-HT,, receptors 85, 380 Ambulatory activity 271 time 437 5-HT,, 123 Amitriptyline 327 Controlled dosing 519 Human 103, 225, 345, 371 Amygdala 189 Corticosteroids 11 Human brain 16 Analgesia 60 Corticosterone 27, 33 Humans 51, 60 Animal behavior 196 Cortisol 153, 313 Animal model 352 Cortisol response 519 Idazoxan 313 Animal model of alcoholism 136 Cotinine 507 Imipramine 23 Animal models of anxiety 205 Cue learning 147 In vitro autoradiography 16 Antagonist 320 "C 16 Individuality 67 Anticholinergic 327 Infantile stimulation 170 Antidepressants 23, 93 Information processing 485 Defensive behavior 205 Antidepressants 327 Inhibitory avoidance learning 131 Demand 1 Antiepileptic drugs 131 Insomnia 67 Dementia 103 Antipredator defense 352 Inverse agonist 185 Dependence 218, 333, 408, 507 Antipsychotics 98 Depression 93 Anxiety 213, 313, 333, 352, 387 Kappa opioid receptor 235 Desipramine 363 Anxiogenic property 205 Ketanserin 27 Development 256 Anxiolysis 229 Ketanserine 210 Diazepam 131, 147, 301, 371 Apomorphine 47, 72, 367 Discrete-trials choice 295 Arginine-vasopressin 225 Late luteal phase dysphoric disorder DO! 27 Arousal 456 153 Dopa decarboxylase 98 Attention 159, 485 Lateralisation 473 Dopamine 72, 177, 189, 256, 345, 367 Aversion 110 Learning 345, 480 Dopamine antagonists 289 Lithium 93 Dose-related 460 Locomotion 177, 196 Behavioral economics 1 Doxazosine 283 Locomotor activity 352, 367 Behaviour 283 DRL 115 Locus coeruleus 23 Benzodiazepine 72, 333 Drug abuse 60 Long-term memory 448 Benzodiazepine agonist, midazolam Drug discrimination 85 Lorazepam 345, 371 229 Drug interactions 115 Benzodiazepine antagonist, flumazenil Drug selfadministration 1 m-chlorophenylpiperazine 225 229 Drug stimulus exposure 495 MCPP 320 Benzodiazepine physical dependence Dynorphin 235 Mecamylamine 417, 480 301 D2 receptors 47 Memory 159, 235, 327, 345, 371, 417, Benzodiazepine receptors 16 443, 452 Benzodiazepines 147, 196, 248, 371 EEG 473 Memory improvement 11 Beta-CCE 205 Electroconvulsive treatment 367 Mesolimbic dopamine system 141 Blood pressure 313 Elevated plus-maze 229 Methamphetamine sensitivity 271 Body weight 501 Emotional reactivity 170 MHPG 313 Brain levels 338 B-endorphin 153 Mice 131, 271, 276, 367 Bromperidol 338 Ethanol 301 Microeconomics 1 Bungarotoxin-receptors 33 Ethanol intake 136 MK-801 115, 271, 352, 367 Buspirone 289, 380 Etoperidone 320 Monkey brain 16 Euphoriant effects 460 Mood 60 Caffeine 51 Examination anxiety 456 Morphine 40, 60, 147, 283 Carbamazepine 131 Excitatory amino acid 110 Morphine-6-glucuronide 60 Carbon monoxide 466 Exploration 170 Morris water maze 147 Vil Motor activity 177, 196 Place learning 147 Sleep 67, 213 mRNA levels 98 Platelet 210 Sleep-wakefulness 263 Positron emission tomography 16, 380 Slow wave sleep 387 N-allylnormetazocine 115 Prefrontal cortex 159 Smokers 519 Naloxone 40, 141, 147 Premenstrual symptoms 153 Smoking 408, 432, 437, 448, 456, 473 Naltrexon 79 Prenatal exposure 256 Snuff 507 Nasal nicotine spray 512 Prepulse inhibition 189 Social status 276 Nicotine 397, 408, 417, 443, 448, 452, Progressive-ratio 295 Spinal cord 123 456, 460, 466, 473, 480, 485, 501, Proponent process 79 Spinal reflexes 123 507, 519 Psychomotor performance 432 Statistical parametric mapping 380 Nicotine effects 512 Psychopharmacological effects 466 Stress 23, 276, 456 Nicotine gum 432 Punishment 185 Striatum 189 Nicotine pharmacokinetics 512 Subjective effects 51 Nicotine regulation 1 Quazepam 248 Subjective response 519 Nicotine replacement treatment 512 Quinpirole 72, 256 Substance withdrawal syndrome 67 Nicotine-tolerance 33 Sulpiride 72 Nicotinic 417 Radial arm maze 72 (+) S-20499 47 Nicotinic cholinergic-stress 33 Rat 40, 47, 147, 185, 229, 263, 283 NMDA antagonist 352 Rat brain 363 Tar 466 NMDA receptor 367 Rats 320 Tobacco use 397 Nociception 123 Rebound insomnia 67, 248 Tolerance 51, 218 Non-match-to-sample task 72 Reinforcement 51 Tomography, single photon emission Nootropics 11 Reinstatement 79 computed 103 nor-binaltorphimine 235 Relapse 79, 218, 495 Trazodone 320 Norepinephrine 313 Repeated administration 271 Triazolam 67, 301 Nucleus accumbens 189 Repetition priming 371 Tricyclics 327 RFT (Reciprocal Forepaw Treading) Tryon rats 136 8-OH-DPAT 85 320 Tryptophan 60 Opiate 218 Rhesus monkey 289, 295 Tyrosine hydroxylase 23, 98 Opiates 177 Ritanserin 213, 263, 387 ['?5!] Tyr’ '-somatostatin binding sites Opioid 218 Ro 15-4513 16 363 Opioid peptides 235 Roman high- and low-avoidance rats Opioid receptor 141 170 UK-14.304 283 Opioids 79, 147 Unit price 1 Opponent process 79 Schedule-controlled behavior 115 U-50,488 235 Oral self-administration 301 Schizophrenia 98 Orbital cortex 189 SCH23390 72 Water consumption 501 Selective breeding 136 Wet-dog shakes 27 Peck-avoidance 235 Self-administration 79, 295 Withdrawal 40, 177, 218, 283 Penile erections 47 Self-administration of drugs 289 Withdrawal-deficit 437 Periaqueductal gray 110 Sensorimotor gating 189 Withdrawal effects 213 Perinatal flumazenil (Ro 15-1788) 170 Serotonin 60, 93, 110, 123, 153, 225, Working/episodic memory 72 FET 16 320 Pharmacological challenge 380 Serotonin receptors 210 Yawning 47 Phencyclidine 115 Serotonin-2 (5-HT2 ) binding site 27 Yohimbine 313 Phenylpropanolamine 501 Sex differences 352 Phenytoin 131 Short-term memory 485 Zacopride 333 Physical dependence 40, 51 SKF38393 72 Zolpidem 248 Physiological response 519 SKF104078 159 Zopiclone 248